Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GermlineCausalMutation
|
disease |
ORPHANET |
Nosology and classification of genetic skeletal disorders: 2010 revision.
|
21438135 |
2011 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
UNIPROT |
To provide additional data for genotype-phenotype analyses and to determine the proportion of mutations in the type I collagen genes among subjects with lethal forms of OI, we sequenced the coding and exon-flanking regions of COL1A1 and COL1A2 in a cohort of 63 subjects with OI type II, the perinatal lethal form of the disease.
|
18996919 |
2009 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
Biomarker
|
disease |
BEFREE |
To provide additional data for genotype-phenotype analyses and to determine the proportion of mutations in the type I collagen genes among subjects with lethal forms of OI, we sequenced the coding and exon-flanking regions of COL1A1 and COL1A2 in a cohort of 63 subjects with OI type II, the perinatal lethal form of the disease.
|
18996919 |
2009 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
UNIPROT |
Osteogenesis imperfecta: clinical, biochemical and molecular findings.
|
16879195 |
2006 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
UNIPROT |
Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV.
|
16786509 |
2006 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
UNIPROT |
Four new cases of lethal osteogenesis imperfecta due to glycine substitutions in COL1A1 and genes. Mutations in brief no. 152. Online.
|
10627137 |
1998 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
UNIPROT |
Three unrelated individuals with perinatally lethal osteogenesis imperfecta resulting from identical Gly502Ser substitutions in the alpha 2-chain of type I collagen.
|
7959683 |
1994 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
UNIPROT |
Determination of a new collagen type I alpha 2 gene point mutation which causes a Gly640 Cys substitution in osteogenesis imperfecta and prenatal diagnosis by DNA hybridisation.
|
7891382 |
1994 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
UNIPROT |
Substitution of an aspartic acid for glycine 700 in the alpha 2(I) chain of type I collagen in a recurrent lethal type II osteogenesis imperfecta dramatically affects the mineralization of bone.
|
8182080 |
1994 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
UNIPROT |
Two additional cases of osteogenesis imperfecta with substitutions for glycine in the alpha 2(I) collagen chain. A regional model relating mutation location with phenotype.
|
7693712 |
1993 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
UNIPROT |
A novel glycine to glutamic acid substitution at position 343 in the alpha 2 chain of type I collagen in an individual with lethal osteogenesis imperfecta.
|
7906591 |
1993 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
BEFREE |
Fibroblast cell strains from three infants with perinatal lethal osteogenesis imperfecta (OI) carry unique mutations in COL1A1 (the gene encoding the pro alpha 1(I) chain of type I procollagen) that impair chain association.
|
8349697 |
1993 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
Biomarker
|
disease |
BEFREE |
Type I procollagen was purified from the medium of dermal fibroblasts cultured from four individuals with osteogenesis imperfecta (OI) type II who had mutations in the COL1A1 gene of type I procollagen.
|
1460046 |
1992 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
UNIPROT |
Defective folding and stable association with protein disulfide isomerase/prolyl hydroxylase of type I procollagen with a deletion in the pro alpha 2(I) chain that preserves the Gly-X-Y repeat pattern.
|
1339453 |
1992 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
UNIPROT |
Incorporation of type I collagen molecules that contain a mutant alpha 2(I) chain (Gly580-->Asp) into bone matrix in a lethal case of osteogenesis imperfecta.
|
1385413 |
1992 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
UNIPROT |
Lethal perinatal osteogenesis imperfecta due to a type I collagen alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatch.
|
1284475 |
1992 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
UNIPROT |
Substitutions for glycine alpha 1-637 and glycine alpha 2-694 of type I procollagen in lethal osteogenesis imperfecta. The conformational strain on the triple helix introduced by a glycine substitution can be transmitted along the helix.
|
1874719 |
1991 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
UNIPROT |
Characterization of point mutations in the collagen COL1A1 and COL1A2 genes causing lethal perinatal osteogenesis imperfecta.
|
2777764 |
1989 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
UNIPROT |
A single base mutation that converts glycine 907 of the alpha 2(I) chain of type I procollagen to aspartate in a lethal variant of osteogenesis imperfecta. The single amino acid substitution near the carboxyl terminus destabilizes the whole triple helix.
|
2914942 |
1989 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
BEFREE |
Heterozygosity for a large deletion in the alpha 2(I) collagen gene has a dramatic effect on type I collagen secretion and produces perinatal lethal osteogenesis imperfecta.
|
3372533 |
1988 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
BEFREE |
These findings demonstrate further heterogeneity in the biochemical basis of osteogenesis imperfecta type II and suggest that the nature and location of mutations in type I procollagen may determine phenotypic variation.
|
2981871 |
1985 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
GeneticVariation
|
disease |
BEFREE |
Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II.
|
4022126 |
1985 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Osteogenesis imperfecta, dominant perinatal lethal
|
0.660 |
Biomarker
|
disease |
CTD_human |
|
|
|